Although germline GATA2 variants are rare events in primary AML [9], GATA2 deficiency is a common driver of pediatric MDS, accounting for approximately 7% of all pediatric MDS and 15% of MDS with excess blasts (MDS-EB) [10, 11]. The gene discussed is GATA2; the disease is acute myeloid leukemia.